Burden of Friedreich’s Ataxia to the Patients and Healthcare Systems in the United States and Canada

Overview of attention for article published in Frontiers in Pharmacology, January 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 1 news outlet

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 2 news stories from 1 outlets.

Larimar Therapeutics: Underweight Cash Burners In More Niche Markets

Seeking Alpha, 28 Oct 2023

Summary Larimar Therapeutics is developing a therapy, CTI-1601, to treat Friedreich's Ataxia, a rare inherited disease.

Reata Pharmaceuticals' Omaveloxolone CRL Appears Imminent

Seeking Alpha, 17 Feb 2023

Follow Summary Reata Pharmaceuticals has submitted a New Drug Application to the US Food and Drug Administration for…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.